Shao Y M, Ayesh S, Stein W D
Silberman Institute of Life Sciences, Hebrew University, Jerusalem, Israel.
Biochim Biophys Acta. 1997 Feb 27;1360(1):30-8. doi: 10.1016/s0925-4439(96)00065-8.
We measured the effects of combinations of verapamil, vinblastine, mefloquine, and tamoxifen, all being modulators of the multidrug resistance pump, P-glycoprotein, on the accumulation of labelled daunomycin into multidrug-resistant P388 leukemia cells at 37 degrees C. We found that, contrary to our initial expectations (based on Ayesh, Shao and Stein (1996) Biochim. Biophys. Acta 1316, 8), vinblastine, mefloquine, and tamoxifen all appeared to interact with one another synergistically, i.e. by the kinetics of a non-competitive interaction. A simple kinetic analysis showed that pairs of co-operating modulators can give apparent non-competitive behaviour, but refined kinetic analysis enables the two types of interaction to be distinguished. The modulators vinblastine, mefloquine, and tamoxifen thus appear to co-operate with one another in pairs to bring about reversal of P-glycoprotein. This may have important implications for the design of new modulators of P-glycoprotein.
我们测定了维拉帕米、长春碱、甲氟喹和他莫昔芬(均为多药耐药泵P-糖蛋白的调节剂)的组合对37℃下标记柔红霉素在多药耐药P388白血病细胞中的积累的影响。我们发现,与我们最初的预期(基于Ayesh、Shao和Stein(1996年)《生物化学与生物物理学报》1316, 8)相反,长春碱、甲氟喹和他莫昔芬似乎都相互协同作用,即通过非竞争性相互作用的动力学。简单的动力学分析表明,成对的协同调节剂可呈现明显的非竞争性行为,但精细的动力学分析能够区分这两种相互作用类型。因此,调节剂长春碱、甲氟喹和他莫昔芬似乎成对相互协同作用,以实现P-糖蛋白的逆转。这可能对新型P-糖蛋白调节剂的设计具有重要意义。